Let’s get right to the point.
No one has time to wait for answers. That’s why we developed QScout™ RLD (Rapid Leukocyte Differential). It reports a white blood cell and differential count at patient-side in about 2 minutes from a drop of blood.* Results include immature infection-fighting cells some labs count manually.
News that counts.
Ad Astra Diagnostics (AAD), developer of rapid diagnostic systems, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its QScout™ rapid-result hematology system, which provides fast, point-of-care white blood cell counts (WBCs), neutrophil-to-lymphocyte ratio, and differentiates the number and percent of five types of mature WBCs as well as immature granulocytes - see full press release
Forget the hassle.
QScout™ RLD requires no lengthy machine startup time or sample prep. No wet reagents that need to be changed or disposed. No pumps. Only a drop of blood. It goes from powered off to your first result in about 3 minutes. It’s easy to use with minimal training.
See the difference.
It’s an imaging-based system not prone to the challenges of flow cytometry or the Coulter Principle. Cells are examined directly by a trained computer using AI instead of indirect measures like light scatter or electrical resistance.
If you’re an investigator interested in clinical trials, please contact us.